Kelly A. Demerino
Corporate Officer/Principal bei NUVO PHARMACEUTICALS INC.
Profil
Kelly A.
Demerino is currently working as the Vice President-Financial Operations at Nuvo Pharmaceuticals, Inc. Prior to this role, Ms. Demerino attended Mount Allison University, where they completed their undergraduate degree.
Aktive Positionen von Kelly A. Demerino
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Kelly A. Demerino
| Mount Allison University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
